The initial face validity of the article supports the widely held concept of localized drug delivery by modalities used in physical therapist practice. I have several questions regarding the article, many of which are related primarily to the methods; however, as a mentor of mine once taught me, in pharmacology research, the devil is in the details. I address the issues in order of concern.
No analytical methods were presented or referenced. This results in the majority of my subsequent concerns. As these methods are the basis for all of the results in the article, this is a major omission. Would the Journal have allowed force measurements to be reported in the results without requiring the authors to document the methods and devices utilized for these force measurements? I believe that the same standards should apply to pharmacologic measurements.
The samples were stated as having been "analyzed by a chromatography procedure." This is inaccurate. Chromatography describes a column packed with material for separating and/or concentrating compounds for subsequent detection. There are multiple types of chromatography: gas, high-and low-pressure liquid chromatography, and immunochromatography.
The method of detection was not stated. Analysis of the eluent from the chromatographic column may be by absorbance with a Go Back spectrophotometer, fluorescence with a fluorometer, mass spectroscopy, or immunodetection with an enzyme-linked immunoassay.
Often when tissue is being analyzed for drug concentrations, several preparation steps are required. These steps may include homogenization, wet-wet extraction, or solid phase chromatography extractions. None of these were mentioned.
The level of detection for plasma (0.002 µg/mL) was stated, but no similar detection limits were stated for adipose or synovial tissues. In my research on the tissue detection of ketoprofen, I found that minimal drug detection concentrations vary as much as 100-fold, based on the tissue matrix.
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Within the results section, the plasma levels were stated in the nanogram per milliliter range. However, the tissue levels were in the microgram per gram range and that is approximate to microgram per milliliter range for most tissues. Were different extraction procedures used, or were different standard curves used?
Were dimerization or additional chemical reactions required to achieve these drug detection levels? Other studies 1-3 have suggested that, to obtain this level of detection, some type of enhancement in spectrophotometric absorbance or fluorometric emission may be required. Additional procedural steps have the potential to result in erroneous (false positive) results if they are not controlled.
Were the samples with unknown drug concentrations compared with a standard curve of the drug in the same matrix? Again, if the standard curve for determining the concentration of the drug in a tissue is not derived from the same matrix, erroneous interpretation of the results may occur. In addition, if the unknowns were not analyzed in duplicate, were both intra-day and inter-day coefficients of determination conducted to examine the reproducibility of the results in the unknown samples?
With the previous concerns in mind, I also question the ketoprofen variation in the various tissues reported in the results. My own research on ketoprofen iontophoresis 2, 3 and that of other researchers in transcutaneous drug delivery 4,5 indicates that the theoretical construct and experimental evidence support both the concept of the drug concentrations being greatest at the surface of the skin and the drug concentration in the tissue decreasing with increasing tissue depth.
Although Cagnie et al addressed this concern in their discussion section, I am uncertain whether they gave this pharmaco-kinetic construct the significance it deserves. The permeation of drugs from the surface of the skin to deeper tissue sites should result in an inverse drug concentrationtissue depth response curve. I agree that local vascular effects may result in penetration deeper than the integument without systemic vascular delivery; however, to date, there is no significant experimental pharmacokinetic evidence to support this theory.
In conclusion, although the article provides face validity for the capacity of phonophoresis to provide localized deep tissue drug penetration, due to major methods omissions the data are not reproducible, and the results should be viewed with some skepticism. I would discourage readers from using the article to document the value of phonophoresis in providing localized drug delivery. 
